Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Am J Respir Crit Care Med
2 Antimicrob Agents Chemother
1 J Bacteriol
1 J Infect
1 J Infect Dis
1 Lancet
8 PLoS One
1 Trop Med Int Health

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Respir Crit Care Med

  1. ROSSER A, Pareek M, Turapov O, Wiselka MJ, et al
    Differentially Culturable Tubercule Bacilli are Generated During Non-pulmonary Tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Sep 7. doi: 10.1164/rccm.201705-1048.
    PubMed     Text format    

    Antimicrob Agents Chemother

  2. HUSZAR S, Singh V, Polcicova A, Barath P, et al
    N-Acetylglucosamine-1-phosphate transferase, WecA, as a validated drug target in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01310.
    PubMed     Text format     Abstract available

  3. PARK SW, Tasneen R, Converse PJ, Nuermberger EL, et al
    Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01502.
    PubMed     Text format     Abstract available


  4. PANDA S, Swaminathan S, Hyder KA, Christophel EM, et al
    Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.
    BMJ. 2017;358:j3545.
    PubMed     Text format    

    J Bacteriol

  5. REICHLEN MJ, Leistikow RL, Scobey MS, Born SEM, et al
    Anaerobic Mycobacterium tuberculosis cell death stems from intracellular acidification mitigated by the DosR regulon.
    J Bacteriol. 2017 Sep 5. pii: JB.00320-17. doi: 10.1128/JB.00320.
    PubMed     Text format     Abstract available

    J Infect

  6. SHAH R, Nabiswa H, Okinda N, Revathi G, et al
    The Diagnostic Accuracy Of Determine Tb Lam Antigen In Detection Of Extra Pulmonary Tuberculosis (Eptb).
    J Infect. 2017 Sep 4. pii: S0163-4453(17)30268.
    PubMed     Text format    

    J Infect Dis

  7. GUPTA S, Cheung L, Pokkali S, Winglee K, et al
    Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
    J Infect Dis. 2017;215:1883-1887.
    PubMed     Text format     Abstract available


  8. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    PubMed     Text format    

    PLoS One

  9. CLOUSE K, Blevins M, Lindegren ML, Yotebieng M, et al
    Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.
    PLoS One. 2017;12:e0171384.
    PubMed     Text format     Abstract available

  10. GETAHUN B, Nkosi ZZ
    Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2017;12:e0171209.
    PubMed     Text format     Abstract available

  11. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available

  12. KHAPARDE S, Raizada N, Nair SA, Denkinger C, et al
    Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
    PLoS One. 2017;12:e0184270.
    PubMed     Text format     Abstract available

  13. PHILLIPS BL, Gautam US, Bucsan AN, Foreman TW, et al
    LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model.
    PLoS One. 2017;12:e0180413.
    PubMed     Text format     Abstract available

  14. MARANGU D, Mwaniki H, Nduku S, Maleche-Obimbo E, et al
    Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting.
    PLoS One. 2017;12:e0183749.
    PubMed     Text format     Abstract available

  15. BAGUMA R, Penn-Nicholson A, Smit E, Erasmus M, et al
    Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
    PLoS One. 2017;12:e0184563.
    PubMed     Text format     Abstract available

  16. MONTANE E, Barriocanal AM, Arellano AL, Valderrama A, et al
    Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae(R) in adults with or without latent TB infection: Safety and immunogenicity.
    PLoS One. 2017;12:e0171294.
    PubMed     Text format     Abstract available

    Trop Med Int Health

  17. SIDDIQUI AN, Khayyam KU, Siddiqui N, Sarin R, et al
    Diabetes Prevalence and its Impact on Health-Related Quality of Life in Tuberculosis Patients.
    Trop Med Int Health. 2017 Sep 4. doi: 10.1111/tmi.12968.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.